Lindsey Rolfe

Dr. Rolfe is Executive Vice President of Clinical and Pre-clinical Development and Pharmacovigilance and Chief Medical Officer at Clovis Oncology. At Clovis, Dr. Rolfe has overseen the development team that obtained approvals for Rubraca as an ovarian cancer treatment in the US and Europe and is responsible for all pre-and post-marketing medical activities.